Auricular Pressure for Postoperative Pain After Hemorrhoidectiomy: a Randomized Controlled Trial
Pilot Study of Clinical Randomized Controlled Trial of Auricular Pressure Therapy for Intervention of Postoperative Pain of Hemorrhoidectiomy
1 other identifier
interventional
80
1 country
1
Brief Summary
Auricular pressure is effective for postoperative analgesia after hemorrhoidectomy, but the evidence is not sufficient.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable postoperative-pain
Started Mar 2020
Typical duration for not_applicable postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 17, 2019
CompletedFirst Posted
Study publicly available on registry
October 1, 2019
CompletedStudy Start
First participant enrolled
March 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2021
CompletedFebruary 18, 2020
February 1, 2020
1.3 years
September 17, 2019
February 15, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale(VAS)
It is a unidimensional measure providing a simple solution for measuring subjective experience. The VAS scale is a 10-cm line with 0 cm indicating no symptoms and 10 cm indicates the greatest extent of symptoms. Twenty-four hours after the operation, VAS\>3 in the case of an analgesic pump can be included in the randomized control group.
Day 1 after randomization.
Secondary Outcomes (3)
Hospital Anxiety and Depression scale(HAD)
Twenty-four hours, three days, and seven days after surgery
The utilization rate of analgesic drugs(Diclofenac Sodium Dual Release Enteric-coated Capsules)
Day 7 after randomization.
Amount of analgesic drugs (Diclofenac Sodium Dual Release Enteric-coated Capsules)
Day 7 after randomization.
Other Outcomes (1)
Tissue edema
Day 3, day4, day5, day6 and day7 after randomization.
Study Arms (2)
Auricular pressure
EXPERIMENTALUse wangbuliuxing seed to stimulate auricular acupuncture point.
Sham auricular pressure
SHAM COMPARATORUse wangbuliuxing seed to stimulate auricular acupuncture point.
Interventions
Select related auricular points: Shenmen(TF4), sympathetic(AH6a), rectum(HX2), anus(HX5), stomach(CO4), subcortical(AT4). The auricle skin of the patient was disinfected 24 hours after the operation, and wanghuoxing seed will be used for stimulation. Ask patients press every two hours for one minute at each point. When the pain is severe, do pressure compressions at each point for 2 minutes once hour.
Select unrelated auricular points: eye(LO5), occipital(AT3), tonsil(LO7,8,9), lower auricular root(R3), dorsum auricular kidney(P5) and dorsum auricular lung(P2). The auricle skin of the patient was disinfected 24 hours after the operation, and wanghuoxing seed will be used for stimulation. Ask patients press every two hours for one minute at each point. When the pain is severe, do pressure compressions at each point for 2 minutes once hour.
Eligibility Criteria
You may qualify if:
- Meet the diagnostic criteria of grade II-IV mixed hemorrhoids and meet the operation conditions;
- Age 18\~65;
- External stripping and internal ligation of mixed hemorrhoids, general anesthesia or lumbar shu point anesthesia;
- VAS score ≥3 points after the implementation of analgesia pump;
- Improve clinical auxiliary examination and sign informed consent.
You may not qualify if:
- Combined with inflammatory hemorrhoids, thrombotic hemorrhoids, perianal eczema, perianal abscess and other perianal diseases that affect the evaluation of curative effect;
- Combined with intestinal infectious diseases, intestinal polyps, rectal malignant tumors, etc;
- Combined with severe cardiovascular disease, immune deficiency, mental disorder, or severe liver and kidney dysfunction;
- Auricle skin lesions or auricle skin allergy to tape is difficult to tolerate treatment;
- Combined cognitive impairment could not complete the efficacy; evaluation;
- Pregnancy or planned pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chengdu University of Traditional Chinese Medicine
Chengdu, Sichuan, 610075, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hui Zheng, PhD
Chengdu University of Traditional Chinese Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 17, 2019
First Posted
October 1, 2019
Study Start
March 1, 2020
Primary Completion
July 1, 2021
Study Completion
July 1, 2021
Last Updated
February 18, 2020
Record last verified: 2020-02